Susquehanna International Group’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
Other funds holding CDLX
CIP
VCM
6CM
KGAMU
WPM
RC
QOP
Susquehanna International Group's CDLX Position: Q1 2026 in Review
Susquehanna International Group reduced its Cardlytics (CDLX) stake by 88% in Q1 2026, selling an estimated $119K and leaving 1,592 shares worth $16.7K. The position accounts for ﹤0.01% of the portfolio, ranked #12886.
Susquehanna International Group first reported a position in CDLX in Q3 2019 and has held it in 24 quarters since. The position peaked at $4.22M in Q4 2020. 58 funds tracked by Wall St. Rank hold CDLX as of Q1 2026.
- Susquehanna International Group held 1,592 shares of Cardlytics worth $16.7K as of Q1 2026.
- Susquehanna International Group sold 12,195 Cardlytics shares in Q1 2026, an estimated $119K.
- Cardlytics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12886 holding.
- Susquehanna International Group first reported a position in Cardlytics in Q3 2019 and has held it in 24 quarters since.
- Susquehanna International Group's Cardlytics position peaked at $4.22M in Q4 2020.
- 58 funds tracked by Wall St. Rank held Cardlytics as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.